NO20002214L - FremgangsmÕte for syntese av pyrrolaminer - Google Patents

FremgangsmÕte for syntese av pyrrolaminer

Info

Publication number
NO20002214L
NO20002214L NO20002214A NO20002214A NO20002214L NO 20002214 L NO20002214 L NO 20002214L NO 20002214 A NO20002214 A NO 20002214A NO 20002214 A NO20002214 A NO 20002214A NO 20002214 L NO20002214 L NO 20002214L
Authority
NO
Norway
Prior art keywords
reaction
pyrrolamines
synthesis
followed
cycloakane
Prior art date
Application number
NO20002214A
Other languages
English (en)
Other versions
NO20002214D0 (no
Inventor
John Anthony Ragan
Teresa Woodall Makowski
David Jon Am Ende
Pamela Jane Clifford
Gregory Randall Young
Alyson Kay Conrad
Shane Allen Eisenbeis
Douglas John Meldrum Allen
George Joseph Quallich
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20002214D0 publication Critical patent/NO20002214D0/no
Publication of NO20002214L publication Critical patent/NO20002214L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Tea And Coffee (AREA)
  • Fats And Perfumes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
NO20002214A 1997-11-13 2000-04-28 FremgangsmÕte for syntese av pyrrolaminer NO20002214L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6542297P 1997-11-13 1997-11-13
US7426698P 1998-02-10 1998-02-10
PCT/IB1998/001672 WO1999025684A1 (en) 1997-11-13 1998-10-21 Method of synthesis of pyrrole amides

Publications (2)

Publication Number Publication Date
NO20002214D0 NO20002214D0 (no) 2000-04-28
NO20002214L true NO20002214L (no) 2000-05-12

Family

ID=26745584

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002214A NO20002214L (no) 1997-11-13 2000-04-28 FremgangsmÕte for syntese av pyrrolaminer

Country Status (35)

Country Link
US (1) US6262272B1 (no)
EP (1) EP1030838B1 (no)
JP (1) JP3497469B2 (no)
KR (1) KR100386722B1 (no)
CN (2) CN1280566A (no)
AT (1) ATE231492T1 (no)
AU (1) AU745788B2 (no)
BG (1) BG64530B1 (no)
BR (1) BR9814161A (no)
CA (1) CA2310095A1 (no)
CZ (1) CZ20001769A3 (no)
DE (1) DE69810959T2 (no)
DK (1) DK1030838T3 (no)
DZ (1) DZ2651A1 (no)
EA (1) EA002243B1 (no)
ES (1) ES2186232T3 (no)
HR (1) HRP20000298A2 (no)
HU (1) HUP0100235A3 (no)
ID (1) ID24135A (no)
IL (1) IL135710A0 (no)
IS (1) IS5469A (no)
MA (1) MA24697A1 (no)
NO (1) NO20002214L (no)
NZ (1) NZ503916A (no)
OA (1) OA11378A (no)
PA (1) PA8462901A1 (no)
PL (1) PL340554A1 (no)
PT (1) PT1030838E (no)
SK (1) SK6872000A3 (no)
TN (1) TNSN98204A1 (no)
TR (1) TR200001343T2 (no)
TW (1) TW509675B (no)
UY (1) UY25249A1 (no)
WO (1) WO1999025684A1 (no)
YU (1) YU27300A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200200544T2 (tr) * 1999-08-31 2002-06-21 Neurogen Corporation Bağlı pirolkarboksamitler: gaba beyin alıcı ligantları
JP2004508359A (ja) 2000-09-06 2004-03-18 ニューロゲン コーポレイション アリール置換テトラヒドロインダゾール、及び、gaba−a受容体に対するリガンドとしてのそれらの使用
JP2004515491A (ja) * 2000-12-04 2004-05-27 ファイザー・プロダクツ・インク 縮合ピロールカルボキサミド類の合成
US6852730B2 (en) 2002-02-07 2005-02-08 Neurogen Corporation Substituted fused pyrazolecarboxylic acid arylamides and related compounds
US20080153629A1 (en) * 2004-05-07 2008-06-26 Sullivan Michael J Thick Outer Cover Layer Golf Ball
CN102786458B (zh) * 2012-06-04 2014-02-12 天津渤海职业技术学院 吡咯甲酰胺衍生物、其制备方法和用途
MX2016009621A (es) * 2014-01-24 2016-11-17 Abbvie Inc Derivados de fur0-3-carboxamida y metodos de uso.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750702A (en) 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
US5484944A (en) 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
AU2218997A (en) * 1996-03-22 1997-10-10 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands

Also Published As

Publication number Publication date
DE69810959D1 (de) 2003-02-27
IL135710A0 (en) 2001-05-20
PT1030838E (pt) 2003-03-31
DK1030838T3 (da) 2003-02-24
PL340554A1 (en) 2001-02-12
SK6872000A3 (en) 2002-02-05
EP1030838B1 (en) 2003-01-22
WO1999025684A1 (en) 1999-05-27
HUP0100235A3 (en) 2002-04-29
ATE231492T1 (de) 2003-02-15
NO20002214D0 (no) 2000-04-28
EA002243B1 (ru) 2002-02-28
HUP0100235A2 (hu) 2001-12-28
HRP20000298A2 (en) 2001-02-28
OA11378A (en) 2004-01-27
UY25249A1 (es) 1999-07-19
BG64530B1 (bg) 2005-06-30
CZ20001769A3 (cs) 2001-09-12
TW509675B (en) 2002-11-11
EA200000413A1 (ru) 2000-12-25
DZ2651A1 (fr) 2003-03-15
AU745788B2 (en) 2002-03-28
JP3497469B2 (ja) 2004-02-16
CN1280566A (zh) 2001-01-17
ES2186232T3 (es) 2003-05-01
KR20010032063A (ko) 2001-04-16
BG104413A (en) 2001-02-28
CN1508129A (zh) 2004-06-30
IS5469A (is) 2000-04-26
KR100386722B1 (ko) 2003-06-09
YU27300A (sh) 2002-10-18
BR9814161A (pt) 2000-09-26
EP1030838A1 (en) 2000-08-30
ID24135A (id) 2000-07-06
TNSN98204A1 (fr) 2005-03-15
JP2001523660A (ja) 2001-11-27
TR200001343T2 (tr) 2001-02-21
US6262272B1 (en) 2001-07-17
AU9363998A (en) 1999-06-07
CA2310095A1 (en) 1999-05-27
DE69810959T2 (de) 2003-06-05
MA24697A1 (fr) 1999-07-01
NZ503916A (en) 2002-08-28
PA8462901A1 (es) 2000-05-24

Similar Documents

Publication Publication Date Title
PL326452A1 (en) Method of synthesising composunds being affinite to curcumine
TR200000456T2 (tr) Glufosinatların ve ara ürünlerinin üretimine dair yöntem.
DE69813792D1 (de) Zwischenprodukte und verfahren zu ihrer herstellung
DE69307699T2 (de) Verfahren zur herstellung substituierter aromatischer amine
NO20002214L (no) FremgangsmÕte for syntese av pyrrolaminer
DK0787124T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aminobenzonitriler
EA199900821A1 (ru) Способ получения производных пиразола
WO2002048098A1 (fr) Arylbis (perfluoroalkylsulfonyl) methane, son sel metallique et leurs procedes de production
PT72801A (en) Process for synthesis of substituted biphenyl-2-carboxaldehydes
NO985775D0 (no) FremgangsmÕte til fremstilling av aminocyanacetamid
HK1027560A1 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
ATE247641T1 (de) Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten
EP0739885A4 (en) METHOD FOR PRODUCING 3-ISOXAZOLE CARBONIC ACID
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
PT922686E (pt) Processo para a producao de etinilciclopropano
DE59908757D1 (de) Verfahren zur herstellung von atropasäureethylester
IL133719A0 (en) Method for the production of n-(5-amino-2-cyano-4- fluorophenyl) - sulphonamides and new intermediate products
HUP9900171A2 (hu) Eljárás azo-metinek és alfa-halogén-acetanilidek előállítására
EP0079592A3 (en) Catalyst stabilization
MX9504739A (es) Procedimiento para la obtencion de colorantes cationicos del 1,3,4-tiadiazol.
NO20005058D0 (no) FremgangsmÕte for fremstilling av 4,4-dimetyl-5<alfa>- cholesta-8,14,24-trien-3<beta>-ol og mellomprodukter erholdt ved fremgangsmÕten